Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Emmanuel Colombo

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Breast Cancer Research and Treatment|September 22, 2018
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impactGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Gynecologic Oncology|August 8, 2025
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian DatabaseClaire Chator, Marion Chevrier, Jean-Sébastien Frenel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2023
Efficacy of chemotherapy according to <i>BRCA</i> status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapseFlora Brouillard-Saby, Caroline Saint-Martin, Isabelle Ray-Coquard, et al.
British Journal of Cancer|November 29, 2024
ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironmentMarine Bruciamacchie, Véronique Garambois, Nadia Vie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2026
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer databaseSophie Le Bars, Catherine Guerin-Charbonnel, Elodie Martin, et al.
Gynecologic Oncology|August 15, 2022
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohortQuentin Dominique Thomas, Amal Boussere, Jean-Marc Classe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 18, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME databaseThomas Papazyan, Elodie Martin, Patricia Pautier, et al.
Journal of Gynecologic Oncology|July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG networkThomas Gaillard, Judicael Hotton, Enora Laas, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 1, 2020
Machine Learning-Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer ScreeningRita Tanos, Guillaume Tosato, Amaelle Otandault, et al.
International Journal of Molecular Sciences|December 11, 2022
Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous CarcinomaAnna Paula Carreta Ruano, Andrea Paiva Gadelha Guimarães, Alexcia C Braun, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Breast Cancer Research and Treatment|September 22, 2018
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impactGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Gynecologic Oncology|August 8, 2025
Role of platinum-free interval (PFI) and maintenance therapies in recurrent ovarian cancer to explain survival. An analysis from the French real-world ESME Ovarian DatabaseClaire Chator, Marion Chevrier, Jean-Sébastien Frenel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2023
Efficacy of chemotherapy according to <i>BRCA</i> status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapseFlora Brouillard-Saby, Caroline Saint-Martin, Isabelle Ray-Coquard, et al.
British Journal of Cancer|November 29, 2024
ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironmentMarine Bruciamacchie, Véronique Garambois, Nadia Vie, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 21, 2026
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer databaseSophie Le Bars, Catherine Guerin-Charbonnel, Elodie Martin, et al.
Gynecologic Oncology|August 15, 2022
Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohortQuentin Dominique Thomas, Amal Boussere, Jean-Marc Classe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 18, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME databaseThomas Papazyan, Elodie Martin, Patricia Pautier, et al.
Journal of Gynecologic Oncology|July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG networkThomas Gaillard, Judicael Hotton, Enora Laas, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 1, 2020
Machine Learning-Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer ScreeningRita Tanos, Guillaume Tosato, Amaelle Otandault, et al.
International Journal of Molecular Sciences|December 11, 2022
Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous CarcinomaAnna Paula Carreta Ruano, Andrea Paiva Gadelha Guimarães, Alexcia C Braun, et al.
Pageof 9